FTXH

First Trust Nasdaq Pharmaceuticals ETF

$31.34

+0.00%

Market closed. Last update: 11:40 PM ET

📎 Investment Objective

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) seeks to provide investment results that correspond generally to the price and yield performance of the Nasdaq US Pharmaceutical Index.

Overview

ETF tracking First Trust Nasdaq Pharmaceuticals ETF

Category Technology

Issuer First Trust

Inception Date 2016-09-21

Market Cap $17.2M

Average Volume N/A

Dividend Yield 1.48%

52-Week Range $23.57 - $31.50

VWAP $31.47

Performance

Loading performance data...

Price Chart

Investment Summary

📎 Investment Objective

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) seeks to provide investment results that correspond generally to the price and yield performance of the Nasdaq US Pharmaceutical Index.

🎯 Investment Strategy

The fund invests at least 90% of its net assets in the common stocks and depositary receipts that comprise the Nasdaq US Pharmaceutical Index. The index is designed to track the performance of companies engaged in the research, development, manufacture, and distribution of pharmaceuticals and drugs.

✨ Key Features

Focuses on the pharmaceutical and drug development industry
Tracks the Nasdaq US Pharmaceutical Index, which includes both large and mid-cap companies
Low expense ratio of 0.00%
Relatively new fund with limited performance history

⚠️ Primary Risks

Concentration risk as the fund is focused on a single industry sector
Potential volatility due to the dynamic nature of the pharmaceutical industry
Limited diversification as the fund tracks a narrow index
Lack of long-term performance history to evaluate the fund's consistency

👤 Best For

This ETF may be suitable for investors seeking exposure to the pharmaceutical and drug development sector as part of a diversified portfolio. However, due to the fund's limited history and narrow focus, it may be more appropriate for investors with a higher risk tolerance and a long-term investment horizon.